Download PDF
Thromb Haemost 1998; 80(03): 525-526
DOI: 10.1055/s-0037-1615245
Letters to the Editor
Schattauer GmbH

Recurrent Venous Thrombosis despite Correction of Activated Protein C Resistance following Orthotopic Liver Transplantation

Douwe H. Biesma
1   From the Department of Internal Medicine
,
Rob A. de Man
2   St Antonius Hospital, Nieuwegein, Department of Gastroenterology
,
Karel H. Nieuwenhuis
3   Erasmus University Hospital, Rotterdam, and Department of Haematology, University Hospital, Utrecht, The Netherlands
,
Fred J. L. M. Haas
4   From the Department of Clinical Chemistry
› Author Affiliations
Further Information

Publication History

Received 09 March 1998

Accepted after revision 08 March 1998

Publication Date:
08 December 2017 (online)

Also available at
    Permissions and Reprints

 

 

  • References

  • 1 Koster T, Rosendaal FR, de Ronde H, Briët E, Vandenbroucke JP, Bertina RM. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet 1993; 342: 1503-6.
    CrossrefPubMedGoogle Scholar
  • 2 Cox D, O’Kennedy R, Thornes RD. The rarity of liver toxicity in patients treated with coumarin (1,2-benzopyrone). Human Toxicology 1989; 8: 501-6.
    CrossrefPubMedGoogle Scholar
  • 3 Slagboom G, Loeliger EA. Coumarin-associated hepatitis. Report of two cases. Archives of Internal Medicine 1980; 140: 1028-9.
    CrossrefPubMedGoogle Scholar
  • 4 De Man RA, Wilson JHP, Schalm SW, ten Cate FJW, Van Leer E. Phenprocoumon-induced hepatitis mimicking non-A, non-B hepatitis. Journal of Hepatology 1990; 11: 318-21.
    CrossrefPubMedGoogle Scholar
  • 5 Hohler T, Schnutgen M, Helmreich-Becker L, Mayet WJ, Mayer zum Buschenfelde KH. Drug-induced hepatitis: a rare complication of oral anticoagulants. Journal of Hepatology 1994; 21: 447-9.
    CrossrefPubMedGoogle Scholar
  • 6 McCarthy M, Gane E, Pereira S, Tibbs CJ, Heaton N, Rela M, Hambley H, Williams R. Liver transplantation for haemophiliacs with hepatitis C cirrhosis. Gut 1996; 39: 870-5.
    CrossrefPubMedGoogle Scholar
  • 7 Vanrenterghem Y, Roels L, Lerut T, Gruwez J, Michielsen P, Gresele P, Deckmyn H, Colucci M, Arnout J, Vermylen J. Thromboembolic complications and haemostatic changes in cyclosporin-treated cadaveric kidney allo-graft recipients. Lancet 1985; i: 999-1002.
    PubMedGoogle Scholar
  • 8 Cohen H, Neild GH, Patel R, Mackie IJ, Machin SJ. Evidence for chronic platelet hyperaggregability and in vivo activation in cyclosporin-treated renal allograft recipients. Thrombosis Research 1988; 49: 91-101.
    PubMedGoogle Scholar
  • 9 Tracy PB, Eide LL, Bowie EJW, Mann KG. Radioimmunoassay of factor V in human plasma and platelets. Blood 1982; 60: 59-63.
    PubMedGoogle Scholar
  • 10 Nesheim ME, Nichols WL, Cole TL, Houston JG, Schenk RB, Mann KG, Bowie EJ. Isolation and study of an acquired inhibitor of human coagulation factor V. Journal of Clinical Investigation 1986; 77: 405-15.
    CrossrefPubMedGoogle Scholar